Identifying effect modifiers of CAR-T cell therapeutic efficacy: a systematic review and individual patient data meta-analysis protocol

被引：0
作者：
Manoj M. Lalu
Natasha Kekre
Joshua Montroy
Maryam Ghiasi
Kevin Hay
Scott McComb
Risini Weeratna
Harold Atkins
Brian Hutton
Ayel Yahya
Ashish Masurekar
Mohamad Sobh
Dean A. Fergusson
机构：
[1] Ottawa Hospital Research Institute,Centre for Practice
[2] The Ottawa Hospital,Changing Research, Office L1298a, Clinical Epidemiology Program
[3] Ottawa Hospital Research Institute,Department of Anesthesiology and Pain Medicine
[4] University of British Columbia,Blood and Marrow Transplant Program
[5] National Research Council of Canada,Department of Medicine
[6] University of Ottawa,Division of Medicine, Department of Hematology
[7] University of Ottawa,School of Epidemiology and Public Health
来源：
Systematic Reviews | / 12卷
关键词：
Systematic review; Individual patient data meta-analysis; CAR-T cell therapy; Oncology; Protocol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 176 条
[1]  
Poon LM(2013)Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation Biology Blood Marrow Transpl 19 1059-1064
[2]  
Hamdi A(2014)Chimeric antigen receptor T cells for sustained remissions in leukemia N Engl J Med 371 1507-1517
[3]  
Saliba R(2017)Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma N Engl J Med 377 2531-2544
[4]  
Rondon G(2020)KTE-X19 CAR T-cell therapy in relapsed or refractory mantle-cell lymphoma N Engl J Med 382 1331-1342
[5]  
Ledesma C(2019)Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma N Engl J Med 380 45-56
[6]  
Kendrick M(2015)T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial Lancet. 385 517-528
[7]  
Maude SL(2014)Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia Sci Transl Med 6 224ra25-733
[8]  
Frey N(2011)Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia N Engl J Med 365 725-31
[9]  
Shaw PA(2013)T cells expressing chimeric antigen receptors can cause anaphylaxis in humans Cancer Immunol Res 1 26-110
[10]  
Aplenc R(2019)Risks and benefits of chimeric antigen receptor T-cell (CAR-T) therapy in cancer: a systematic review and meta-analysis Transfus Med Rev 33 98-1335
12345678910